Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company...

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 11:26am EDT

Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to
Make Company Presentations at AdvaMed 2008

 

Innovative and High Growth MedTech Companies to Present September 22-24, 2008 

WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- More than 50 U.S. and
international medical technology companies have been selected to present at
AdvaMed 2008: The MedTech Conference.  Company presentations offer a unique
business development and information sharing opportunity for innovators and
market leaders in the cardiovascular, dental, diagnostics, imaging, metabolic
disease/obesity, neurology, ophthalmology, orthopedics/spine, and wound care
sectors.

"These dynamic companies were selected to present by a committee of leading
business development and licensing executives, venture capitalists, bankers,
and industry experts and will showcase a spectrum of cutting-edge medical
innovations at varying stages in the product development lifecycle," said
Kenneth Mendez, AdvaMed's Chief Administrative Officer. "In addition to the
plenary sessions, MedTech partnering, and more than 50 educational panels,
these company presentations offer investors and corporate business development
officers the opportunity to identify projects and companies for potential
investment, business collaboration and licensing activities." 

Next Generation companies selected to present for 8 minutes include:
-- 20/20 GeneSystems (Rockville, Maryland)
-- Adnavance Technologies (San Diego, California)
-- Apeliotus Vision Science (Atlanta, Georgia)
-- Avita Medical (Cambridge, United Kingdom)
-- BioControl Medical (Yehud, Israel)
-- BioMarker Strategies (Baltimore, Maryland)
-- Chemica Technologies, Inc (Beaverton, Oregon)
-- Crospon (Galway, Ireland)
-- Endovalve, Inc. (Princeton, New Jersey)
-- eSight Corporation (Ottawa, Canada)
-- eToims Medical Technology LLC (Philadelphia, Pennsylvania)
-- Mesynthes (Wellington, New Zealand)
-- MicroTransponder, Inc. (Dallas, Texas)
-- NovaVision (Boca Raton, Florida)
-- PEAK Surgical, Inc. (Palo Alto, California)
-- Therapeutic Monitoring Systems, Inc. (Ottawa, Canada)
-- Urovalve, Inc. (Newark, New Jersey)
-- Veralight (San Ramon, California)

14-Minute presentations will be provided by:
-- AcryMed (Medical Device Infection Control; Beaverton, Oregon)
-- Allegro Diagnostics, Inc. (Diagnostics; Boston, Massachusetts)
-- Axial Biotech (Diagnostics; Salt Lake City, Utah)
-- BD (Diagnostics; Franklin Lakes, New Jersey)
-- BioCure, Inc. (Orthopedics/Spine; Norcross, Georgia)
-- BoneGrafix, Inc. (Dental; Rockville, Maryland)
-- Cohera Medical (Wound Care; Pittsburgh, Pennsylvania)
-- Critical Care Innovations, Inc. (Oncology; Fairfax, Virginia)
-- CVRx, Inc. (Cardiovascular; Minneapolis, Minnesota)
-- Deltex Medical (Evidence-based Medicine; Chichester, United Kingdom)
-- Dymedix Corporation (Sleep Disordered Breathing; Shoreview, Minnesota)
-- Elcam Medical, Inc. (Critical Care/Anesthesia; Hackensack, New Jersey)
-- Elminda (Next Generation; Tirat Hacarmel, Israel)
-- g-NOstics Ltd (Diagnostics; Didcot, United Kingdom)
-- Ikonisys, Inc. (Diagnostics; New Haven, Connecticut)
-- ISTO Technologies, Inc. (Orthopedics/Spine; St Louis, Missouri)
-- Ivivi Technologies (Cardiovascular; Montvale, New Jersey)
-- Life Recovery Systems (Cardiovascular; Waldwick, New Jersey)
-- MagForce Nanotechnologies AG (Oncology/Cancer; Berlin, Germany)
-- Medtronic, Inc. (Corporation Overview/All Categories; Minneapolis,
Minnesota)
-- Medtronic, Inc. (Orthopedics/Neurology; Minneapolis, Minnesota)
-- MicroPhage, Inc. (Diagnostics; Longmont, Colorado)
-- mNEMOSCIENCE GmbH (Biomaterials; Aachen, Germany)
-- mtm laboratories, AG (Diagnostics; Westborough, Massachusetts)
-- Nanomix, Inc. (Diagnostics; Emeryville, California)
-- Nerites Corporation (Tissue Repair; Madison, Wisconsin)
-- Nitric BioTherapeutics, Inc. (Wound Care; Bristol, Pennsylvania)
-- Noxilizer, Inc. (Enabling Technology; Bethesda, Maryland)
-- Orla Protein Technologies Ltd (Diagnostics; Newcastle Upon Tyne, United
Kingdom)
-- OrSense Ltd. (Cardiovascular; Nes Ziona, Israel)
-- ProDrive Systems (Dental; Montreal, Canada)
-- Quidel Corporation (Diagnostics; San Diego, California)
-- RS Medical (Orthopedics/Spine; Vancouver, Washington)
-- Scientific Intake (Metabolic Disease/Obesity; Atlanta, Georgia)
-- Seno Medical Instruments, Inc. (Imaging; San Antonio, Texas)
-- Symbios Medical Products, LLC (Pain Management; Indianapolis, Indiana)
-- SyntheMed, Inc. (Cardiovascular; Iselin, New Jersey)
-- ThromboVision, Inc. (Cardiovascular; Houston, Texas)
-- VitalWear (Orthopedics/Spine; South San Francisco, California)
-- Xylos Corporation (Orthopedics/Spine; Langhorne, Pennsylvania)

For more information about the company presentation schedule or the conference
visit AdvaMed 2008: The MedTech Conference visit www.AdvaMed2008.com, call
(202) 434-7213, or e-mail info@AdvaMed2008.com.  Specific questions about
Company Presentations should be sent to busdev@AdvaMed2008.com.  Host sponsors
for AdvaMed 2008:The MedTech Conference include Covidien, Ernst & Young,
Johnson & Johnson and Kaplan EduNeering.

About AdvaMed:
AdvaMed member companies produce the medical devices, diagnostic products and
health information systems that are transforming health care through earlier
disease detection, less invasive procedures and more effective treatments. Our
members produce nearly 90 percent of the health care technology purchased
annually in the United States and more than 50 percent purchased annually
around the world. AdvaMed members range from the largest to the smallest
medical technology innovators and companies. For more information, visit
www.AdvaMed.org.

About AdvaMed 2008:
Designed by industry for industry, AdvaMed 2008 is the premier MedTech
conference for business executives, policymakers, media, financiers, and
service providers from around the world. In its inaugural year, AdvaMed 2007
attracted more than 400 organizations and 1,100 industry leaders - including
300+ CEOs, Presidents and C-level executives. 

With more than 1,400 senior level attendees expected, AdvaMed 2008 is this
year's can't miss event for networking; conducting partnering meetings;
educating and influencing policymakers and the media; and participating in
education sessions. Whether you need to finance, partner or license
technology, AdvaMed 2008 introduces you to key decision-makers. Learn more at
www.AdvaMed2008.com.

Editor's note: Media interested in covering these company presentations or
AdvaMed 2008 should apply to receive a media registration code by calling
Alicia at 410-991-7027 or e-mailing a request to media@advamed2008.com.
Pre-registration is encouraged.






SOURCE  AdvaMed; AdvaMed 2008

Alicia Moran of AdvaMed 2008, +1-410-991-7027; or Wanda Moebius, AdvaMed,
+1-202-434-7240
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.